Non-AIDS-defining malignancies in HIV patients: Clinical features and perspectives;Les nouvelles tumeurs malignes du patient infecté par le VIH: Aspects cliniques et perspectives

Bulletin du Cancer

Volumn 93, Issue 1, 2006, Pages 37-42

  Spano, Jean Philippe ^a   Carcelain, Guislaine ^a   Katlama, Christine ^a   Costagliola, Dominique ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

HIV infection; Malignant tumor

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANUS CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; OUTCOME ASSESSMENT; PATIENT CARE; PROGNOSIS; REVIEW; SKIN CANCER; TREATMENT OUTCOME;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; MORBIDITY; NEOPLASMS; PROGNOSIS;

EID: 33144474096     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Cheung MC, Pantanowitz L, Dezube BJ. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist 2005; 10: 412-6.
2. Bonnet F, Lewden C, May T, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 2004; 101: 317-24.
3. Spano JP, Faivre S. Non-Aids related malignancies: prognostic and treatment. Bull Cancer 2003; 90: 413-8.
4. Besson C, Goubar A, Gabarre J, et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001; 98: 2339-44.
5. Tirelli U, Errante D, Dolcetti R, et al. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative group on AIDS and Tumor (GI-CAT). J Clin Oncol 1995; 13: 1758-67.
6. Herida M, Mary-Krause M, Kaphan R, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003; 21: 3447-53.
7. Rabkin CS, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst 1994; 86: 1711-6.
8. Launay O, Guillevin L. Epidemiology of HIV-associated malignancies. Bull Cancer 2003; 90: 387-92.
9. Tirelli U, Spina M, Sandri S, et al. Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and tumors. Cancer 2000; 88: 563-9.
10. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998; 351: 1833-9.
11. Grulich AE, Wan X, Law MG, Coates M, Kaldor JM. Risk of cancer in people with AIDS. AIDS 1999; 13: 839-43.
12. Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 2001; 154: 544-56.
13. Frisch M, Biggar RJ, Engels EA, Goedert JJ. AIDS-Cancer match registry study group. JAMA 2001; 285: 1736-45.
14. Clifford GM, Polesel J, Rickenbach, et al. Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005; 97: 425-32.
15. Herndier BJ, Sanchez HC, Chang KL, Chen YY, Weiss LM. High prevalence of Eipstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease. Am J Pathol 1993; 142: 1073-9.
16. Spano JP, Massiani MA, Bentata M, et al. Lung cancer in patients with HIV infection and review of the literature. Med Oncol 2004; 21: 109-15.
17. Karp J, Profeta G, Marantz PR, Karpel JP. Lung cancer in patients with immunodeficiency syndrome. Chest 1993; 103: 410-3.
18. Sridhar KS, Flores MR, Raub Jr. W, Saldana M. Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects. Chest 1992; 102: 1704-8.
19. Vyzula R, Remick SC. Lung cancer in patients with HIV infection. Lung Cancer 1996; 15: 325-39.
20. Alshafie MT, Donaldson B, Oluwole SF. Human immunodeficiency virus and lung cancer. Br J Surg 1997; 84: 1068-71.
21. Frisch M. On the etiology of anal squamous carcinoma. Dan Med Bull 2002; 49: 194-209.
22. Frisch M, Glimelius B, van den Brule AJC, et al. Begnin anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma. Br J Cancer 1998; 78: 1534-8.
23. Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, et al. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001; 184: 547-51.
24. Piketty C, Darragh TM, Heard I, et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004; 31: 96-9.
25. Spano JP, Marcelain AG, Carcelain G. HPV et cancer. Bull Cancer 2005; 92: 59-64.
26. Hoster S. Is anal carcinoma a HAART-related problem? Eur J Med Res 2003; 8: 142-6.
27. Ortholan C, François E, Gérard JP. Preneoplastic anal lesions and anal carcinoma. Bull Cancer 2003; 90: 405-11.
28. Einstein MH, Kadish AS. Anogenital neoplasia in AIDS. Curr Opin Oncol 2004; 16: 455-62.
29. Penn I. Immunosuppression and skin cancer. Clin Plast Surg 1980; 7: 361-8.
30. Wang CY, Brodland DG, Su WPD. Skin cancers associated with acquires immunodeficiency syndrome. Mayo Clin Proc 1995; 70: 766-72.
31. Milburn PB, Brandsma JC, Goldsman C, et al. Disseminated warts and evolving squamous cell carcinoma in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol 1988; 19: 401-5.
32. Fiorino AS, Atac B. Paraproteinemia, plasmacytema, myeloma and HIV infection. Leukemia 1997; 11: 2150-6.
33. Kumar S, Kumar D, Schnadig VJ, et al. Plasma cell myeloma in patients who are HIV-positive. Am J Clin Pathol 1994; 102: 633-9.
34. Jin DK, Nowakowski M, Kramer M, et al. Hyperviscosity syndrome secondary to a myeloma-associated IgG(1) kappa paraprotein strongly reactive against the HIV-1 p24 gag antigen. Am J Hematol 2000; 64: 210-3.
35. Voelkerding KV, Sandhaus LM, Kim HC, et al. Plasma cell malignancy in the acquired immune deficiency syndrome. Association with Epstein-Barr virus. Am J Clin Pathol 1989; 92: 222-8.
36. Konrad RJ, Kricka LJ, Goodman DB, et al. Brief report: myeloma-associated paraprotein directed against the HIV-1p24 antigen in an HIV-1-seropositive patient. N Engl J Med 1993; 328: 1817-9.
37. kentos A, Vekemans M, Van Vooren JP, et al. High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier. Bone Marrow Transplant 2002; 29: 273-5.
38. Lyter DW, Bryant J, Thackeray R, et al. Incidence of human immunodeficiency virus-related and non-related malignancies in a large cohort of homosexual men. J Clin Oncol 1995; 13: 2540-6.
39. Fizzazi K, Amato RJ, Beuzeboc P, et al. Germ cell tumors in patients infected by the human immunodeficiency virus. Cancer 2001; 92: 1460-7.
40. Bernardi D, Salvioni R, Vaccher E, et al. Testicular germ cell tumors and human immunodeficiency virus infection: a report of 26 cases. J Clin Oncol 1995; 13: 2705-11.
41. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92: 1500-10.
42. Pantonowitz L, Connolly JL. Pathology of the breast associated with HIV/AIDS. Breast J 2002; 8: 234-43.
43. Amir H, Kaaya EE, kwesigabo G, et al. Breast cancer before and during the AIDS epidemic in women and men: a study of Tanzanian Cancer Registry Data 1988 to 1996. J Natl Med Assoc 2000; 92: 301-5.
44. Pantanowitz L, Dezube BJ. Breast cancer in women with HIV/AIDS. JAMA 2001; 285: 3090-1.
45. Pantanowitz L, Dezube BJ. Reasons for a deficit of breast cancer among HIV-infected patients. J Clin Oncol 2004; 22: 1347-8.
46. Stewart T, Tsai SC, Grayson H, et al. Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet 1995; 346: 796-8.
47. Van Hoeven KH, Factor SM, Kress Y, Woodruff JM. Visceral myogenic tumors: a manifestation of HIV infection in children. Am J Surg Pathol 1993; 17: 1176-81.
48. Goedert JJ. The epidemiology of acquired immunodificiency syndrome malignancies. Sem Oncol 2000; 27: 390-401.